Patient Navigation for Colorectal Cancer Screening (SCREEN Trial)

N/A

Waitlist Available

Research Sponsored by Medstar Health Research Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 45-75

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

No Placebo-Only Group

Summary

This trial will study how patient navigation can increase screening rates among racial and ethnic minorities in primary care practices. They will implement patient navigation and reminders in 15 clinics using various strategies like assessing readiness, feedback

Who is the study for?

This trial is for individuals from racial and ethnic minorities who are due for colorectal cancer screening. It aims to understand how well a patient navigation program works in different primary care clinics.

What is being tested?

The study tests the effectiveness of patient navigation, reminders, and other strategies to improve colorectal cancer screening rates across 15 clinics using a stepped-wedge randomized design over five six-month steps.

What are the potential side effects?

Since this trial involves non-medical interventions like patient navigation and reminders, there are no direct medical side effects associated with it.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 45 and 75 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Colorectal cancer screening completion

Secondary study objectives

Acceptability measured by the Acceptability of Intervention Measure (AIM)

Adoption

Appropriateness measured by the Intervention Appropriateness Measure (IAM)

+3 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Patient navigationExperimental Treatment1 Intervention

Patient navigation will be rolled out at the clinic level (15 clinics). Referral orders will become available to participating clinics, with education and audit and feedback for providers. The study team will tailor patient navigation supports by clinic site for specifics on how the intervention is delivered.

Group II: Usual careActive Control1 Intervention

0 / 1Eligibility criteria met